Literature DB >> 11682933

A review of cervical cancer patients presenting in Harare and Parirenyatwa Hospitals in 1998.

Z M Chirenje1, S Rusakaniko, V Akino, M Mlingo.   

Abstract

OBJECTIVE: To document the socio-demographic profile, presenting symptoms, disease stage and treatment modality offered to all women attending Harare and Parirenyatwa Hospitals with a histological diagnosis of invasive cervical cancer in 1998.
DESIGN: A cross sectional study.
SETTING: Parirenyatwa Hospital and Harare Central Hospital.
SUBJECTS: All women with a histological diagnosis of cervical cancer admitted between 11 January 1998 and 14 December 1998 were recruited into the study.
RESULTS: A total of 196 patients, with a median age of 47 years (range 24 to 80 years) were recruited into the study. A high proportion (63.3%) of the women were from rural areas. The mean age at first pregnancy was 17.9 years (SD 2.8) and 112 (63.3%) first sought treatment at the primary health care centre. Persistent vaginal discharge was the most frequent (69.4%) presenting complaint. One hundred and ninety five patients (99.5%) had histological confirmation of invasive cervical cancer (91.8% squamous cell carcinoma, 7.7% adenocarcinoma). Clinical staging by The International Federation of Gynaecology and Obstetrics (FIGO) classification confirmed that the majority (80.3%) of the cancers had spread from the cervix into the parametrium and beyond (stage 2b and above) at the time of presentation. Radiation therapy was the most commonly used (77.0%) treatment modality.
CONCLUSION: This study demonstrates that the burden of cervical cancer occurs around the peak age of 47 years and that the majority of women present with advanced disease. None of the women had ever been screened for cervical cancer. The planned introduction of a cervical cancer screening programme by visual inspection of the cervix with acetic acid (VIA), together with a health education campaign may result in a shift towards more women presenting with early curable cervical cancer cases.

Entities:  

Mesh:

Year:  2000        PMID: 11682933     DOI: 10.4314/cajm.v46i10.8566

Source DB:  PubMed          Journal:  Cent Afr J Med        ISSN: 0008-9176


  6 in total

Review 1.  Optimal management of cervical cancer in HIV-positive patients: a systematic review.

Authors:  Atara Ntekim; Oladapo Campbell; Dietrich Rothenbacher
Journal:  Cancer Med       Date:  2015-07-01       Impact factor: 4.452

2.  Human immunodeficiency virus seroprevalence in patients with invasive cervical cancer in Zaria, North-Western Nigeria.

Authors:  Adamu Abdullahi; Muhammad Inuwa Mustapha; Dawotola Ayorinde David; Olasinde Tajudeen Ayodeji
Journal:  Ann Afr Med       Date:  2018 Jan-Mar

Review 3.  The Prospect and Challenges to the Flow of Liquid Biopsy in Africa.

Authors:  Dada Oluwaseyi Temilola; Martha Wium; Tangbadioa Herve Coulidiati; Henry Ademola Adeola; Giuseppina Maria Carbone; Carlo Vittorio Catapano; Luiz Fernando Zerbini
Journal:  Cells       Date:  2019-08-09       Impact factor: 6.600

4.  The Cost of Locally Advanced Cervical Cancer in Thailand: an Empirical Study for Economic Analysis.

Authors:  Kanyarat Katanyoo; Arthorn Riewpaiboon; Usa Chaikledkaew; Montarat Thavorncharoensap
Journal:  Asian Pac J Cancer Prev       Date:  2021-10-01

Review 5.  Cervical cancer prevention and treatment research in Africa: a systematic review from a public health perspective.

Authors:  Sarah Finocchario-Kessler; Catherine Wexler; May Maloba; Natabhona Mabachi; Florence Ndikum-Moffor; Elizabeth Bukusi
Journal:  BMC Womens Health       Date:  2016-06-04       Impact factor: 2.809

6.  Cervical cancer in Zimbabwe: a situation analysis.

Authors:  Oppah Kuguyo; Alice Matimba; Nomsa Tsikai; Thulani Magwali; Mugove Madziyire; Muchabayiwa Gidiri; Collet Dandara; Charles Nhachi
Journal:  Pan Afr Med J       Date:  2017-07-21
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.